In Treatment for Multiple Myeloma
Bispecific antibodies for myeloma: Managing cytokine release syndrome and infection risk
Learn how to manage CRS and infection risks during bispecific antibody therapy for multiple myeloma. Expert tips for patient safety and side effect care in








